Senior Director
Carelon Research
Wilmington, United States
Dr. Daniel C. Beachler is the senior director and business owner of the Safety & Epidemiology team at Carelon Research, Inc. In this role, Dr. Beachler oversees the execution of pharmacoepidemiology, risk management, and medical product safety studies for a portfolio of industry, academic, and government clients.
He has experience conducting validation studies and utilizing predictive modeling and machine learning methods in order to develop claims-based algorithms to improve cohort and outcome classification. He has also been involved with post authorization safety studies (PASS), Risk Evaluation and Mitigation Strategy (REMS) studies, and post-market requirement (PMR) studies. Prior to joining Carelon Reserach, Dr. Beachler was a Cancer Prevention Fellow at the National Cancer Institute, Division of Cancer Epidemiology and Genetics.
Dr. Beachler has published dozens of manuscripts in the peer-reviewed medical literature. He has presented his work at scientific meetings and to regulatory authorities worldwide.
He holds an MHS and PhD in Epidemiology from Johns Hopkins School of Public Health and a BS in Bioengineering from The Pennsylvania State University.
Disclosure information not submitted.
Using Pharmacoepidemiology Database Resources to Address Drug Safety Research
Saturday, August 24, 2024
2:30 PM – 6:00 PM CEST
Real ID: Methods and Validation in Pregnancy
Wednesday, August 28, 2024
8:30 AM – 10:00 AM CEST